American Portfolios Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,163
Closed -$215K 2989
2019
Q3
$215K Sell
2,163
-615
-22% -$58.4K 0.02% 691
2019
Q2
$257K Buy
2,778
+448
+19% +$42.5K 0.02% 609
2019
Q1
$220K Sell
2,330
-427
-15% -$37.3K 0.02% 609
2018
Q4
$177K Buy
2,757
+206
+8% +$15.2K 0.02% 552
2018
Q3
$228K Buy
2,551
+260
+11% +$23K 0.03% 533
2018
Q2
$182K Buy
2,291
+147
+7% +$12.2K 0.02% 587
2018
Q1
$191K Sell
2,144
-2,737
-56% -$263K 0.03% 533
2017
Q4
$509K Buy
+4,881
New +$551K 0.08% 247

Other funds holding CELG

American Portfolios Advisors's CELG Position: Q4 2019 in Review

American Portfolios Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,163 shares — an estimated $215K sold.

American Portfolios Advisors first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $509K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • American Portfolios Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 2,163 Celgene Corp shares in Q4 2019, an estimated $215K.
  • American Portfolios Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • American Portfolios Advisors's Celgene Corp position peaked at $509K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on American Portfolios Advisors's 13F filing for Q4 2019, filed 24 Mar 2023.